Cargando…

Expert-Agreed Practical Recommendations on the Use of Cladribine

Cladribine is a disease-modifying selective immune reconstitution oral therapy for adult patients with highly active relapsing multiple sclerosis (RMS). It was approved in the USA in 2019 and in Europe in 2017, thus there are still gaps in existing guidelines for using cladribine tablets in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meca-Lallana, Virginia, García Domínguez, José M., López Ruiz, Rocío, Martín-Martínez, Jesús, Arés Luque, Adrián, Hernández Pérez, Miguel A., Prieto González, José M., Landete Pascual, Lamberto, Sastre-Garriga, Jaume
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447968/ https://www.ncbi.nlm.nih.gov/pubmed/36068429 http://dx.doi.org/10.1007/s40120-022-00394-0

Ejemplares similares

Expert opinion on the use of cladribine tablets in clinical practice
por: Sørensen, Per Soelberg, et al.
Publicado: (2020)

Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
por: Yamout, Bassem I, et al.
Publicado: (2022)

Most Experts Agree … But What About Other EEG Readers?
por: Noe, Katherine
Publicado: (2020)

Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
por: Rieckmann, Peter, et al.
Publicado: (2021)

Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
por: Clavelou, Pierre, et al.
Publicado: (2023)

Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015)

Corrigendum to Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Publicado: (2022)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
por: Fernández, Óscar, et al.
Publicado: (2023)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
por: Fernández, Óscar, et al.
Publicado: (2023)

Revista de Neurología cumple medio siglo
por: Sastre-Garriga, Jaume
Publicado: (2023)

Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use
por: Hoffmann-Eßer, Wiebke, et al.
Publicado: (2018)

Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
por: Centonze, Diego, et al.
Publicado: (2023)

Even experts cannot agree on the optimal use of platelet-rich plasma in lateral elbow tendinopathy: an international Delphi study
por: Evans, Jonathan P., et al.
Publicado: (2021)

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)

Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?
por: Arriaza, María José, et al.
Publicado: (2022)

Surgeons agree more on treatment recommendations than on classification of proximal humeral fractures
por: Brorson, Stig, et al.
Publicado: (2012)

Clinical guidelines of UTIs in children: quality appraisal with AGREE II and recommendations analysis
por: Zhu, Binhui, et al.
Publicado: (2022)

Application of population pharmacokinetics to cladribine
por: Lindemalm, Synnöve, et al.
Publicado: (2005)

Cladribine: Lymphopenia: case report
Publicado: (2021)

Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
por: Barrero, Francisco, et al.
Publicado: (2020)

Evaluation of clinical practice guidelines using the AGREE instrument: comparison between data obtained from AGREE I and AGREE II
por: Seto, Kanako, et al.
Publicado: (2017)

Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
por: Inshasi, Jihad S., et al.
Publicado: (2021)

Euthanasia: agreeing to disagree?
por: Holm, Søren
Publicado: (2010)

CERN budgets agreed
por: CERN Press Office. Geneva
Publicado: (1973)

Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Cladribine modifies functional properties of microglia
por: Jørgensen, L. Ø., et al.
Publicado: (2020)

Cladribine: Lymphopenia: 2 case reports
Publicado: (2020)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Research priorities for non-pharmacological therapies for common musculoskeletal problems: nationally and internationally agreed recommendations
por: Foster, Nadine E, et al.
Publicado: (2009)

Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study
por: Sánchez-de la Rosa, Rainel, et al.
Publicado: (2015)

Let’s agree to agree: The situational academic quality of the UK REF as consensual public knowledge
por: Milyaeva, Sveta, et al.
Publicado: (2023)

What information can we gain from the quality appraisal of guidelines with physical activity recommendations for cancer patients?A systematic review using the AGREE II and AGREE-REX tools
por: Zhou, Xue, et al.
Publicado: (2023)

Testicular microlithiasis: Is there an agreed protocol?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

First Draft of Agreed Bill
Publicado: (1916)

When Grammar and Parsing Agree
por: Mancini, Simona
Publicado: (2018)

We Should Agree to Disagree
por: Park, Joon Soo, et al.
Publicado: (2021)

Erdheim Chester Disease treated successfully with cladribine
por: Azadeh, Natalya, et al.
Publicado: (2016)

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
por: Savic, Radojka M., et al.
Publicado: (2017)

Cladribine Tablets: A Review in Relapsing MS
por: Deeks, Emma D.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_un2ellu6as93e75ol973rull2e